Plain-English translation of NCT04890938 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our COPD research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
The STRIVE trial is testing whether a new approach to treating COPD can help patients who have frequent flare-ups. The approach has two parts: doctors will use sputum samples (phlegm you cough up) to guide which medications you take, and you'll receive comprehensive care management — meaning a nurse and case manager will help you manage your condition, teach you about your disease, and coordinate your care between the hospital and clinic.
Many people with COPD have flare-ups over and over again, which leads to hospital visits and a lower quality of life. This trial wants to see if using sputum testing to personalize treatment, along with extra support and education, can reduce how often these flare-ups happen and keep patients healthier.
You likely qualify if…
You likely don't qualify if…
If you join the treatment group, you'll receive 6 months of personalized care that includes clinic visits at 2, 6, and 16 weeks after leaving the hospital. At these visits, a nurse will check your inhaler technique, a case manager will help coordinate your care, and you'll have a sputum sample analyzed to guide what medications you should take. You'll also receive education to help you manage your COPD at home. The comparison group will receive standard COPD care with similar clinic visits but without the sputum-guided treatment decisions.
AI-generated summary from trial data · Jun 26, 2026 · Not medical advice
Canada